High-performance liquid chromatography demonstrates effective enantiomeric analysis of chiral carboxylic acids, suggesting a reliable method for purity assessment.
An indirect high-performance liquid chromatographic method was developed for the enantiomeric analysis of pharmaceutically relevant chiral carboxylic acids, including (±)-2-fluoro-α-methyl-4-biphenylacetic acid, (±)-2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid, and (±)-2-(3-phenoxyphenyl)propionic acid The enantiomeric analytes were converted into diastereomeric anhydrides via activation of the carboxyl group with N-hydroxybenzotriazole in the presence of dicyclohexylcarbodiimide and 4-dimethylaminopyridine, employing a twofold molar excess of the chiral derivatizing reagent to ensure complete derivatization without kinetic resolution. Chromatographic separation was achieved on a reversed-phase column using triethylammonium phosphate buffer (10 mM, pH 3.5) with acetonitrile as organic modifier; a linear gradient of 25–75 % acetonitrile over 45 min at 1.0 mL min −1 afforded baseline resolution, improved peak symmetry, and reduced analysis time compared to methanol-based systems. The method exhibited excellent linearity over the range 25–250 ng mL −1 (R 2 ≥ 0.97), with satisfactory precision (RSD 2.6–5.4 %) and accuracy (recoveries 89.5–101.6 %). The developed method is well suited for routine enantiomeric purity assessment of chiral carboxylic acid drug candidates.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: